Calies Menard-Katcher1, Glenn T Furuta. 1. Digestive Health Institute, Section of Pediatric Gastroenterology, Hepatology and Nutrition, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colo., USA.
Abstract
BACKGROUND/AIMS: Monitoring inflammation associated with eosinophilic esophagitis (EoE) relies on the identification of biomarkers that provide an objective measure of disease activity. To date, this metric has been the number of eosinophils in the squamous epithelial tissue. The search for alternative biomarkers as well as alternative methods to capture them has been the topic of much research. METHODS: Based on clinical experience and a review of the literature, the aim of this chapter is to identify potential EoE biomarkers and methods to assess them. RESULTS: With respect to the biomarkers, a number of candidates have arisen, including peripheral blood eosinophils, eosinophil granule proteins, Th2-related cytokines and exhaled nitric oxide. Methods to assess these biomarkers have included peripheral blood, luminal lavages and breath collections. CONCLUSIONS: Future research will identify the best clinical outcome measure for EoE. While mucosal eosinophilia currently serves as a well-defined metric of inflammation, newer research studies will continue to address whether this number correlates reliably with other patient-reported outcomes, endoscopic findings, molecular analyses or other yet to be defined biomarkers. 2014 S. Karger AG, Basel.
BACKGROUND/AIMS: Monitoring inflammation associated with eosinophilic esophagitis (EoE) relies on the identification of biomarkers that provide an objective measure of disease activity. To date, this metric has been the number of eosinophils in the squamous epithelial tissue. The search for alternative biomarkers as well as alternative methods to capture them has been the topic of much research. METHODS: Based on clinical experience and a review of the literature, the aim of this chapter is to identify potential EoE biomarkers and methods to assess them. RESULTS: With respect to the biomarkers, a number of candidates have arisen, including peripheral blood eosinophils, eosinophil granule proteins, Th2-related cytokines and exhaled nitric oxide. Methods to assess these biomarkers have included peripheral blood, luminal lavages and breath collections. CONCLUSIONS: Future research will identify the best clinical outcome measure for EoE. While mucosal eosinophilia currently serves as a well-defined metric of inflammation, newer research studies will continue to address whether this number correlates reliably with other patient-reported outcomes, endoscopic findings, molecular analyses or other yet to be defined biomarkers. 2014 S. Karger AG, Basel.
Authors: Ulrike von Arnim; Thomas Wex; Friedrich-W Röhl; Helmut Neumann; Dörthe Küster; Jochen Weigt; Klaus Mönkemüller; Peter Malfertheiner Journal: Digestion Date: 2011-11-09 Impact factor: 3.216
Authors: S Jyonouchi; C L Smith; F Saretta; V Abraham; K R Ruymann; P Modayur-Chandramouleeswaran; M-L Wang; J M Spergel; A Cianferoni Journal: Clin Exp Allergy Date: 2014-01 Impact factor: 5.018
Authors: Marc E Rothenberg; Seema Aceves; Peter A Bonis; Margaret H Collins; Nirmala Gonsalves; Sandeep K Gupta; Ikuo Hirano; Chris A Liacouras; Phil E Putnam; Jonathan M Spergel; Alex Straumann; Barry K Wershil; Glenn T Furuta Journal: J Allergy Clin Immunol Date: 2012-09 Impact factor: 10.793
Authors: Carine Blanchard; Emily M Stucke; Beatriz Rodriguez-Jimenez; Karen Burwinkel; Margaret H Collins; Annette Ahrens; Eileen S Alexander; Bridget K Buckmeier Butz; Sean C Jameson; Ajay Kaul; James P Franciosi; Jonathan P Kushner; Philip E Putnam; J Pablo Abonia; Marc E Rothenberg Journal: J Allergy Clin Immunol Date: 2011-01 Impact factor: 10.793
Authors: Chris A Liacouras; Glenn T Furuta; Ikuo Hirano; Dan Atkins; Stephen E Attwood; Peter A Bonis; A Wesley Burks; Mirna Chehade; Margaret H Collins; Evan S Dellon; Ranjan Dohil; Gary W Falk; Nirmala Gonsalves; Sandeep K Gupta; David A Katzka; Alfredo J Lucendo; Jonathan E Markowitz; Richard J Noel; Robert D Odze; Philip E Putnam; Joel E Richter; Yvonne Romero; Eduardo Ruchelli; Hugh A Sampson; Alain Schoepfer; Nicholas J Shaheen; Scott H Sicherer; Stuart Spechler; Jonathan M Spergel; Alex Straumann; Barry K Wershil; Marc E Rothenberg; Seema S Aceves Journal: J Allergy Clin Immunol Date: 2011-04-07 Impact factor: 10.793
Authors: Evan S Dellon; Spencer Rusin; Jessica H Gebhart; Shannon Covey; Leana L Higgins; RoseMary Beitia; Olga Speck; Kimberly Woodward; John T Woosley; Nicholas J Shaheen Journal: Am J Gastroenterol Date: 2015-03-17 Impact factor: 10.864
Authors: E S Dellon; L L Higgins; R Beitia; S Rusin; J T Woosley; R Veerappan; S R Selitsky; J S Parker; R M Genta; R H Lash; R Aranda; R J Peach; M Grimm Journal: Aliment Pharmacol Ther Date: 2016-05-18 Impact factor: 8.171
Authors: John F Bowyer; Karen M Tranter; Joseph P Hanig; Nathaniel M Crabtree; Robert P Schleimer; Nysia I George Journal: PLoS One Date: 2015-07-15 Impact factor: 3.240
Authors: David A Katzka; Thomas C Smyrk; Jeffrey A Alexander; Debra M Geno; RoseMary A Beitia; Audrey O Chang; Nicholas J Shaheen; Rebecca C Fitzgerald; Evan S Dellon Journal: Am J Gastroenterol Date: 2017-08-15 Impact factor: 10.864